Skip to main content

Table 1 Demographics and baseline laboratory markers of mild and severe ill COVID-19 patients in Hefei Cohort

From: Lymphocyte–monocyte–neutrophil index: a predictor of severity of coronavirus disease 2019 patients produced by sparse principal component analysis

 

Mild (N = 54)

Severe (N = 28)

P

Gender = male (%)

28 (51.9)

23 (82.1)

0.015

Smoke = yes (%)

2 (3.7)

0 (0.0)

0.782

Cough = yes (%)

42 (77.8)

20 (71.4)

0.716

Fever = yes (%)

46 (85.2)

22 (78.6)

0.656

Comorbidity = yes (%)

8 (14.8)

16 (57.1)

 < 0.001

Age

40.00 (28.25–50.00)

55.50 (44.75–65.75)

 < 0.001

Blood routine test

 WBC (× 109/L)

4.64 (4.04–5.64)

6.52 (5.13–7.25)

0.004

 NEU%

62.50 (51.38–71.40)

80.50 (73.92–87.62)

 < 0.001

 NEU (× 109/L)

2.69 (2.08–3.76)

5.21 (3.93–6.37)

 < 0.001

 MONO%

7.45 (5.55–8.57)

5.60 (4.45–7.95)

0.043

 MONO (× 109/L)

0.35 (0.26–0.45)

0.34 (0.24–0.56)

0.754

 LYM%

27.45 (21.10–37.72)

12.90 (7.45–18.62)

 < 0.001

 LYM (× 109/L)

1.29 (0.85–1.75)

0.82 (0.49–1.09)

 < 0.001

 RBC (× 1012/L)

4.62 (4.13–5.00)

4.51 (4.37–4.78)

0.685

 Hemaglobin (g/L)

140.00 (122.00–153.75)

140.50 (129.00–144.50)

0.591

 Hematocrit (%)

0.41 (0.37–0.46)

0.42 (0.39–0.43)

0.46

 PLT (× 109/L)

163.50 (135.50–224.25)

162.00 (128.75–202.75)

0.345

Coagulation test

 APTT (s)

38.70 (35.23–43.63)

35.80 (29.67–39.82)

0.019

 TT (s)

13.90 (13.20–14.70)

14.45 (13.85–14.95)

0.045

 Fibrinogen(g/L)

2.73 (1.88–3.40)

3.58 (3.19–4.31)

 < 0.001

 PT (s)

14.45 (13.43–16.38)

14.05 (13.28–14.95)

0.177

 D-dimer (µg/L)

0.19 (0.08–0.28)

0.45 (0.23–0.66)

 < 0.001

Clinical chemistry test

 TBIL (µmol/L)

14.20 (11.20–18.20)

14.75 (9.78–20.23)

0.728

 DBIL (µmol/L)

5.30 (4.40–6.40)

5.80 (4.68–8.97)

0.096

 ALT (U/L)

19.00 (14.00–35.00)

29.00 (23.75–42.25)

0.009

 AST (U/L)

24.00 (20.00–34.00)

31.50 (23.00–39.50)

0.023

 GGT (U/L)

22.00 (17.00–37.00)

42.00 (27.75–64.50)

 < 0.001

 ALP (U/L)

60.00 (48.00–71.00)

60.00 (42.75–81.25)

0.713

 Total protein (g/L)

72.90 (68.60–75.80)

70.25 (66.75–73.45)

0.13

 Albumin (g/L)

44.90 (42.10–48.20)

38.15 (36.00–40.85)

 < 0.001

 Glucose (mmol/L)

5.87 (5.34–6.82)

7.19 (6.43–9.83)

 < 0.001

 Urea (mmol/L)

3.59 (3.02–4.56)

5.71 (4.42–6.58)

 < 0.001

 Creatinine (µmol/L)

69.00 (59.00–82.00)

70.00 (59.50–76.25)

0.941

 Uric acid (µmol/L)

259.00 (206.00–301.00)

204.50 (139.75–296.50)

0.068

 Carbon dioxide (mmol/L)

25.30 (23.80–27.40)

25.70 (23.37–27.93)

0.728

 Potassium (mmol/L)

3.99 (3.71–4.33)

3.97 (3.76–4.09)

0.538

 Sodium (mmol/L)

138.00 (137.00–139.00)

137.00 (134.00–138.00)

0.002

 Chlorine (mmol/L)

102.40 (100.90–104.00)

101.05 (97.95–102.82)

0.009

 Calcium (mmol/L)

2.27 (2.18–2.32)

2.12 (2.08–2.19)

 < 0.001

 Phosphorus (mmol/L)

1.10 (0.97–1.20)

0.96 (0.89–1.14)

0.029

 Magnesium (mmol/L)

0.87 (0.82–0.95)

0.92 (0.83–1.00)

0.06

 Creatine kinase (U/L)

91.70 (55.10–150.10)

87.00 (61.05–167.65)

0.996

 CKMB (U/L)

11.20 (9.10–15.80)

10.00 (9.00–13.00)

0.273

 LDH (U/L)

205.00 (173.00–269.00)

284.00 (251.50–331.50)

 < 0.001

 Myohemoglobin (ng/mL)

30.00 (27.00–33.00)

36.00 (30.00–68.00)

0.004

 Infection-related biomarkers

 Procalcitonin (ng/mL)

0.14 (0.10–0.16)

0.18 (0.13–0.23)

0.002

 Interleukin-6 (pg/ml)

6.20 (5.25–6.83)

7.26 (6.66–9.91)

 < 0.001

 SAA (mg/L)

75.00 (18.43–175.40)

167.50 (118.50–209.88)

 < 0.001

 CRP (mg/L)

5.25 (2.00–21.93)

43.40 (14.52–96.05)

 < 0.001

  1. WBC white blood cell count, LYM lymphocyte count, LYM% lymphocyte percentage, MONO monocyte count, MONO% monocyte percentage, NEU neutrophils count, NEU% neutrophils percentage, RBC red blood cell count, PLT platelet count, PT prothrombin time, APTT activated partial thromboplastin time, TT thrombin time, TBIL total bilirubin, DBIL direct bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma-glutamyltransferase, ALP alkaline phosphatase, CKMB creatine kinase isozyme, LDH lactic dehydrogenase, SAA serum amyloid a, CRP C-reactive protein